Is a high sCD40L level at admission associated with increased in-hospital and 1-year all-cause mortality in patients with STEMI undergoing primary PCI?
Elevated sCD40L at admission may serve as a prognostic biomarker for short- and long-term mortality in STEMI patients treated with primary PCI.
The results of this study suggest that a high sCD40L level at admission is associated with increased in-hospital and 1-year all-cause mortality rates in patients with STEMI undergoing primary PCI.
Püşüroğlu et al. (Tue,) studied this question.